D. Safer

发表

The effect of LSD on sleep-deprived men

D. Safer, 2004, Psychopharmacologia.

Self-Reported Suicide Attempts by Adolescents

D. Safer, 1997, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Carotid Endarterectomy and Prevention of Cerebral Ischemia in Symptomatic Carotid Stenosis

Ralph G. Dacey, William F. Lawrence, Thomas D. Bird, 1991 .

Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.

L. Magder, D. Zarin, D. Safer, 1999, Archives of pediatrics & adolescent medicine.

A Critique on Psychiatric Inpatient Admissions for Suicidality in Youth.

D. Safer, 2021, The Journal of nervous and mental disease.

Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland.

M. Riddle, D. Safer, S. dosReis, 1998, Journal of the American Academy of Child and Adolescent Psychiatry.

Irritable mood and the Diagnostic and Statistical Manual of Mental Disorders.

D. Safer, 2009, Child and adolescent psychiatry and mental health.

The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Children and Adolescents

D. Safer, J. Zito, S. Valluri, 2007 .

Increased methylphenidate usage for attention deficit disorder in the 1990s.

D. Safer, J. Zito, E. Fine, 1996, Pediatrics.

Pemoline hepatotoxicity and postmarketing surveillance.

D. Safer, J. Zito, J. Gardner, 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

Central Stimulant Treatment of Childhood Attention Deficit Hyperactivity Disorder

D. Safer, 1997, CNS drugs.

Overprescribed Medications for US Adults: Four Major Examples

D. Safer, 2019, Journal of clinical medicine research.

Rising prevalence of antidepressants among US youths.

F. Lynch, K. Soeken, M. Boles, 2002, Pediatrics.

Should Selective Serotonin Reuptake Inhibitors Be Prescribed for Children With Major Depressive and Anxiety Disorders?

D. Safer, 2006, Pediatrics.

Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents.

D. Safer, J. Zito, 2006, Journal of child and adolescent psychopharmacology.

Sources of data for pharmacoepidemiological studies of child and adolescent psychiatric disorders.

D. Safer, J. Zito, 1997, Journal of child and adolescent psychopharmacology.

Absence of tolerance to the behavioral effects of methylphenidate in hyperactive and inattentive children.

D. Safer, R. Allen, R. P. Allen, 1989, The Journal of pediatrics.

Atypical antipsychotic use among Medicaid-insured children and adolescents: duration, safety, and monitoring implications.

D. Safer, J. Zito, M. Burcu, 2014, Journal of child and adolescent psychopharmacology.

Growth rebound after termination of stimulant drugs.

D. Safer, R. Allen, E. Barr, 1975, The Journal of pediatrics.

A Comparison of Risperidone-Induced Weight Gain Across the Age Span

D. Safer, 2004, Journal of clinical psychopharmacology.

Do antidepressants reduce suicide rates?

D. Safer, J. Zito, 2007, Public health.

Follow-up survey results of medication used to treat hyperactive school children.

D. Safer, J. Earhart, J. M. Krager, 1979, The Journal of school health.

Diet, Behavior Modification, and Exercise: A Review of Obesity Treatments from a Long‐Term Perspective

D. Safer, 1991, Southern medical journal.

Psychotropic medication for ADHD

D. Safer, J. Zito, 1999 .

The stress of secondary school for vulnerable students

D. Safer, 1986, Journal of youth and adolescence.

Number Needed to Harm: Its Limitations in Psychotropic Drug Safety Research

D. Safer, J. Zito, 2013, The Journal of nervous and mental disease.

Antidepressant prevalence for youths: a multi‐national comparison

H. Tobi, L. de Jong-van den Berg, D. G. Hansen, 2006, Pharmacoepidemiology and drug safety.

The Impact of a State Medicaid Peer-Review Authorization Program on Pediatric Use of Antipsychotic Medications.

D. Safer, J. Zito, M. Burcu, 2017, Psychiatric services.

Antidepressant treatment of Medicaid‐insured youth with a cancer diagnosis

E. Ballard, D. Mattison, D. Safer, 2012 .

Drug Treatment in Child Psychiatry

D. Safer, 1978 .

Factors affecting outcome in a school mental health service

D. Safer, 2005, Community Mental Health Journal.

Psychotropic Medication Patterns Among Youth in Foster Care

D. Safer, J. Zito, J. Gardner, 2008, Pediatrics.

Relative cardiovascular safety of psychostimulants used to treat attention-deficit hyperactivity disorder.

D. Safer, 1992, Journal of child and adolescent psychopharmacology.

Trends in Stimulant Medication Use in Commercially Insured Youths and Adults, 2010-2014.

Howard R. Underwood, D. Safer, J. Zito, 2016, JAMA psychiatry.

Stimulant treatment in Maryland public schools.

D. Safer, M. Malever, Michael Malever, 2000, Pediatrics.

Methylphenidate patterns among Medicaid youths.

L. Magder, M. Riddle, D. Safer, 1997, Psychopharmacology bulletin.

Multiple psychotropic medication use for youths: a two-state comparison.

P. Owens, D. Safer, S. dosReis, 2005, Journal of child and adolescent psychopharmacology.

Psychotropic Medication Patterns in Medicaid-Insured Youth Based on Clinician-Reported Maltreatment Status

D. Safer, J. Zito, M. Burcu, 2014 .

Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.

K. Soeken, D. Safer, I. Zuckerman, 2005, Psychiatric services.

The increased rate of stimulant treatment for hyperactive/inattentive students in secondary schools.

D. Safer, J. M. Krager, 1994, Pediatrics.

Drugs for problem school children.

D. Safer, 1971, The Journal of school health.

Subgrouping conduct disordered adolescents by early risk factors.

D. Safer, 1984, The American journal of orthopsychiatry.

Side Effects from Long-Term Use of Stimulants in Children

D. Safer, R. Allen, R. P. Allen, 1975 .

Depression of growth in hyperactive children on stimulant drugs.

D. Safer, R. Allen, E. Barr, 1972, The New England journal of medicine.

Hyperactivity and Inattentiveness

D. Safer, J. M. Krager, John M. Krager, 1989, Clinical pediatrics.

Treatment of Attention-Deficit Hyperactivity Disorder-Reply

D. Safer, J. M. Krager, 1993 .

Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimens

D. Safer, J. Zito, M. Burcu, 2016, Pharmacoepidemiology and drug safety.

Effect of a media blitz and a threatened lawsuit on stimulant treatment.

D. Safer, J. M. Krager, 1992, Journal of the American Medical Association (JAMA).

Type and prevalence of medication used in the treatment of hyperactive children.

D. Safer, J. M. Krager, 1974, The New England journal of medicine.

Psychotropic practice patterns for youth.

L. Magder, F. Lynch, M. Riddle, 2003 .

Prolactin serum concentrations during aripiprazole treatment in youth.

C. Calarge, D. Safer, A. Safer, 2013, Journal of child and adolescent psychopharmacology.

Changing patterns of psychotropic medications prescribed by child psychiatrists in the 1990s.

D. Safer, 1997, Journal of child and adolescent psychopharmacology.

Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade.

L. Magder, D. Safer, J. Zito, 2013, Psychiatric services.

National Trends in Psychiatric Not Otherwise Specified (NOS) Diagnosis and Medication Use Among Adults in Outpatient Treatment.

D. Safer, J. Zito, M. Burcu, 2016, Psychiatric services.

Trends in the prescribing of psychotropic medications to preschoolers.

F. Lynch, M. Boles, D. Safer, 2000, JAMA.

Recent child pharmacoepidemiological findings.

D. Safer, J. Zito, 2005, Journal of child and adolescent psychopharmacology.

46. The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Children and Adolescents

D. Safer, J. Zito, S. Valluri, 2014 .

Adolescent/Adult Differences in Suicidal Behavior and Outcome

D. Safer, 1997 .

A comparison of studies from the United States and western Europe on psychiatric hospitalization referrals for youths exhibiting suicidal behavior.

D. Safer, 1996, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Psychotropic practice patterns for youth: a 10-year perspective.

L. Magder, F. Lynch, M. Riddle, 2003, Archives of pediatrics & adolescent medicine.

Pharmacoepidemiology of Psychotropic Medications in Youth

D. Safer, J. Zito, 2012 .

Concomitant psychotropic medication for youths.

D. Safer, S. dosReis, J. Zito, 2003, The American journal of psychiatry.

An outpatient/inpatient comparison of child psychiatric diagnosis.

D. Safer, 1995, The American journal of orthopsychiatry.

Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youths.

D. Safer, J. Zito, J. Gardner, 2004, Psychiatric services.

Mental health services for youths in foster care and disabled youths.

K. Soeken, D. Safer, S. dosReis, 2001, American journal of public health.

Psychotropic Medication Patterns in Medicaid-Insured Youth Based on Clinician-Reported Maltreatment Status

D. Safer, J. Zito, M. Burcu, 2013, Journal of Child and Family Studies.

Age-grouped differences in adverse drug events from psychotropic medication.

D. Safer, 2011, Journal of child and adolescent psychopharmacology.

Is ADHD Really Increasing in Youth?

D. Safer, 2018, Journal of attention disorders.

Trends in subthreshold psychiatric diagnoses for youth in community treatment.

D. Safer, J. Zito, M. Burcu, 2015, JAMA psychiatry.

DESIGN AND REPORTING MODIFICATIONS IN INDUSTRY-SPONSORED COMPARATIVE PSYCHOPHARMACOLOGY TRIALS

D. Safer, 2002, The Journal of nervous and mental disease.

Child and Adolescent Psychiatry and Mental Health Off-label Psychopharmacologic Prescribing for Children: History Supports Close Clinical Monitoring

L. Greenhill, C. Kratochvil, D. Safer, 2008 .

The central effects of scopolamine in man.

D. Safer, R. Allen, R. P. Allen, 1971, Biological psychiatry.

National trends in pediatric use of anticonvulsants.

D. Safer, J. Zito, Allen R Tran, 2012, Psychiatric services.

Anticonvulsant treatment for psychiatric and seizure indications among youths.

K. Soeken, D. Safer, J. Zito, 2006, Psychiatric services.

Raising the Minimum Effective Dose of Serotonin Reuptake Inhibitor Antidepressants: Adverse Drug Events

D. Safer, 2016, Journal of clinical psychopharmacology.

Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children.

D. Safer, R. Allen, R. P. Allen, 1973, Pediatrics.

A survey of medication treatment for hyperactive/inattentive students.

D. Safer, J. M. Krager, 1988, JAMA.

Trends in Medication Treatment of Hyperactive School Children

D. Safer, John M. Krager, 1983, Clinical pediatrics.

Stimulant drug treatment of hyperactive adolescents.

D. Safer, R. Allen, R. P. Allen, 1975, Diseases of the nervous system.

Mood swing and mood stabilizer: how specific are these terms?

D. Safer, 2010, Bipolar disorders.

Family Therapy for Children with Behavior Disorders

D. Safer, Daniel J. Safer, 1966 .

Differing antidepressant maintenance methodologies.

D. Safer, 2017, Contemporary clinical trials.

Adolescent/adult differences in suicidal behavior and outcome.

D. Safer, 1997, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and Commentary

D. Safer, J. Zito, Yue Zhu, 2021, Frontiers in Psychiatry.

Recent Trends in Stimulant Usage

D. Safer, 2016, Journal of attention disorders.

Psychotherapeutic medication prevalence in Medicaid-insured preschoolers.

D. Mattison, D. Safer, J. Korelitz, 2007, Journal of child and adolescent psychopharmacology.

A three-country comparison of psychotropic medication prevalence in youth

G. Glaeske, K. Janhsen, D. Safer, 2008, Child and adolescent psychiatry and mental health.

Services and prevention: pharmacoepidemiology of antidepressant use

D. Safer, J. Zito, 2001, Biological Psychiatry.

Parental Perceptions and Satisfaction with Stimulant Medication for Attention‐Deficit Hyperactivity Disorder

K. Soeken, D. Safer, S. dosReis, 2003, Journal of developmental and behavioral pediatrics : JDBP.

Antidepressant Use in Medicaid-Insured Youth: Trends, Covariates, and Future Research Needs

D. Safer, J. Zito, Dinci D Pennap, 2020, Frontiers in Psychiatry.

Short- and Long-Term Antidepressant Clinical Trials for Major Depressive Disorder in Youth: Findings and Concerns

D. Safer, J. Zito, 2019, Front. Psychiatry.

Are Stimulants Overprescribed for Youths with ADHD?

D. Safer, 2000, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

AntipsychoticUsebyMedicaid-Insured Youths:ImpactofEligibilityand PsychiatricDiagnosisAcrossaDecade

L. Magder, D. Safer, J. Zito, 2013 .

Antidepressant treatment in children and adolescents: Bridging the gap between efficacy and effectiveness

D. Safer, J. Zito, 2001, Current psychiatry reports.

Prevalence variations in psychotropic treatment of children.

S. Speedie, M. Riddle, D. Safer, 1998, Journal of child and adolescent psychopharmacology.

Concomitant Use of Atypical Antipsychotics With Other Psychotropic Medication Classes and the Risk of Type 2 Diabetes Mellitus.

L. Magder, D. Safer, G. Rosenthal, 2017, Journal of the American Academy of Child and Adolescent Psychiatry.

International Patterns of Pediatric Medication for Emotional and Behavioral Disorders

D. Safer, J. Zito, 2010 .

Broader clinical considerations in child psychopharmacology practice.

D. Safer, 1983, Comprehensive Psychiatry.

Nonpromotion correlates and outcomes at different grade levels.

D. Safer, D J Safer, Daniel J. Safer, 1986, Journal of learning disabilities.

Socioeconomic factors influencing the rate of non‐promotion in elementary schools

D. Safer, R. Allen, R. Heaton, 1977 .

Hyperactive Children: Diagnosis and Management

D. Safer, R. Allen, R. P. Allen, 1975 .

Factors associated with improvement in severe reading disability

D. Safer, R. Allen, R. P. Allen, 1973 .

Pediatric Bipolar Disorder: Subtype Trend and Impact of Behavioral Comorbidities

D. Safer, J. Zito, M. Burcu, 2014, Journal of clinical medicine.

Behavior therapy for socially ineffective children.

D. Safer, A. Ward, R. Allen, 1975, Journal of the American Academy of Child Psychiatry.

Conjoint play therapy for the young child and his parent.

D. Safer, 1965, Archives of general psychiatry.

Nurse Practitioner Independent Practice Authority and Mental Health Service Delivery in U.S. Community Health Centers.

M. Johantgen, D. Safer, A. Trinkoff, 2017, Psychiatric services.

The effect of heat, cold, and work on the central actions of scopolamine

D. Safer, 1970, Clinical pharmacology and therapeutics.

A motivational environment for behaviorally deviant junior high school students

D. Safer, R. Allen, R. Heaton, 1976, Journal of abnormal child psychology.

Cardiovascular Events Following Treatment Initiation with Atypical Antipsychotic Medications in Publicly Insured U.S. Youth.

L. Magder, D. Safer, G. Rosenthal, 2018, Journal of child and adolescent psychopharmacology.

Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths

L. Magder, D. Safer, G. Rosenthal, 2017, JAMA pediatrics.

Is there a connection between methylphenidate and cancer in youth?

D. Safer, J. Zito, 2007, Pharmacoepidemiology and drug safety.

Planning and Administration

D. Safer, 1986 .

Comparing Nurse Practitioner and Physician Prescribing of Psychotropic Medications for Medicaid-Insured Youths.

D. Safer, A. Trinkoff, J. Zito, 2018, Journal of child and adolescent psychopharmacology.

Lorazepam use during clinical trials of adults with bipolar mania episodes

D. Safer, 2023, Contemporary clinical trials communications.

Major treatment considerations for attention-deficit hyperactivity disorder.

D. Safer, 1995, Current problems in pediatrics.

A familial factor in minimal brain dysfunction

D. Safer, D. Safer, 1973, Behavior genetics.

Age-grouped differences in bipolar mania.

D. Safer, A. Safer, J. Magno Zito, 2012, Comprehensive psychiatry.

A behavioral program for disruptive junior high school students: Results and follow-up

D. Safer, F. Parker, Ronald C. Reaton, 1981, Journal of abnormal child psychology.

Secondary school outcome following a junior high school behavioral program

D. Safer, R. Heaton, 1982 .

Prevalence of medication treatment for hyperactive adolescents.

D. Safer, J. M. Krager, 1985, Psychopharmacology bulletin.

The Impact of Recent Lawsuits on Methylphenidate Sales

D. Safer, 1994, Clinical pediatrics.

The effect of fluphenazine in psychologically normal volunteers: some temporal, performance, and biochemical relationships.

D. Safer, R. Allen, 1971, Biological psychiatry.

Hispanic Residential Isolation, ADHD Diagnosis and Stimulant Treatment among Medicaid-Insured Youth.

D. Safer, J. Zito, M. Burcu, 2017, Ethnicity & disease.

Child and Adolescent Psychiatry and Mental Health Irritable Mood and the Diagnostic and Statistical Manual of Mental Disorders

D. Safer, 2022 .

Number Needed to Harm: Its Limitations in Psychotropic Drug Safety Research

D. Safer, J. Zito, 2013, The Journal of nervous and mental disease.

Recent Trends in Stimulant Usage

D. Safer, 2016, Journal of Attention Disorders.

Child and Adolescent Psychiatry and Mental Health Off-label Psychopharmacologic Prescribing for Children: History Supports Close Clinical Monitoring

L. Greenhill, C. Kratochvil, D. Safer, 2008 .

Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade.

L. Magder, D. Safer, J. Zito, 2013, Psychiatric services.

Atomoxetine: profile report

D. Safer, J. Elia, 2013 .

Prevalence and Management of Hyperactive Children

D. Berwick, D. Safer, C. Kline, 1975 .